Active - Proposal to Strike off12276445Private limited companyLondon

BIOCOMPLIANCE CONSULTANCY LTD

Significant control: Ian Delmage (25–50%), Sally Belinda Delmage (25–50%)

Proposal to strike offThe registrar has published a notice proposing to remove this company from the register. Unless the cause is dealt with or an objection is upheld, it can be dissolved. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.
Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Biocompliance Consultancy Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

BIOCOMPLIANCE CONSULTANCY LTD is an active (proposal to strike off) private limited company (company number 12276445) incorporated on 23 October 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2026, showing net assets of £0, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 100% on the prior period (£3,756). Across the last 3 periods on record the net-asset trend is falling.

Peer position · net assets

By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).

02

Ownership and control

2 active
  • Mr Ian Delmage
    Individual · since 23 October 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Mrs Sally Belinda Delmage
    Individual · since 29 October 2019
    • owns 25–50% of shares

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
23 October 20197 yrs ago
Next accounts due
30 January 2028in 464 days
Confirmation statement due
6 November 2026in 14 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
SIC 74909
Other professional, scientific and technical activities n.e.c.
Accounts type
Micro Entity
Size band
MicroCompanies Act thresholds
05

Financials

3 periods on record · latest ending 30 April 2026
Net assets
£0
−100%vs Oct 2025
Cash at bank
Not reported
Turnover
Not disclosed
Employees
0
vs Oct 2025
Net assets
£0
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 April 2026£0——£0——0
31 October 2025£3,756——£1,135——0
31 October 2024£46k——£6,848——0

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £0 at 30 April 2026
  • Net assets down 25% or more on the prior period-100.0% vs prior period
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 23 October 2019
  • Register status is not ActiveActive - Proposal to Strike off

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 464 days
  2. Confirmation statement duein 14 days
  3. Accounts period endNet assets £0 · micro accounts
  4. Accounts period endNet assets £3,756 · micro accounts
  5. Accounts period endNet assets £46k · micro accounts
  6. Incorporated
08

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for BIOCOMPLIANCE CONSULTANCY LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.